GU Shui-ming

Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial

Rury R. Holman, Ruth L. Coleman, Juliana C.N. Chan et al. · The Lancet Diabetes & Endocrinology · 2017 · 320 citations

Medicine, Cardiology, Pharmacology +16

Therapeutic monitoring of serum digoxin for patients with heart failure using a rapid LC-MS/MS method

Shuijun Li, Gangyi Liu, Jingying Jia et al. · Clinical Biochemistry · 2009 · 43 citations

Pharmacy, Cardiology, Pharmacology +15

Plasma Lp-PLA₂in Acute Coronary Syndrome: Association with Major Adverse Cardiac Events in a Community-Based Cohort

Ning Li, Shuijun Li, Chen Yu et al. · Postgraduate Medicine · 2010 · 18 citations

Medicine, Cardiology, Pharmacology +17

Rare SNP rs12731181 in the miR-590-3p Target Site of the Prostaglandin F _2α Receptor Gene Confers Risk for Essential Hypertension in the Han Chinese Population

Bing Xiao, GU Shui-ming, Mulin Jun Li et al. · Arteriosclerosis Thrombosis and Vascular Biology · 2015 · 16 citations · Full text

Life Sciences, Molecular Biology, Molecular Genetics +17